A few weeks ago, we wrote about a positive test for latent tuberculosis and treating that infection with antibiotics. On the heels of that column, we received some follow-up questions from readers.

PharmaJet’s Needle-free intradermal (ID) injection device (“Tropis® ID”) will be evaluated as delivery system for the tuberculin skin test (TST) in a clinical study conducted by REDE-TB. The study ...

The following scenario emphasizes the necessity of creating a wheal while administering the Mantoux test. A 46-year-old Asian man who recently immigrated to the United States was seen for routine ...

Add Yahoo as a preferred source to see more of our stories on Google. Tuberculosis, or TB, is a disease that infects nearly 11 million people worldwide, killing some 1.25 million of them every year, ...

Tuberculosis, or TB, an airborne bacterial respiratory infection, is one of humanity's oldest foes and is today the world's leading cause of death from infectious disease, claiming more than 1.2 ...

A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much of the world, ...

Kansas is experiencing its largest tuberculosis outbreak in history, with 67 active cases and two deaths. The outbreak is contained to specific areas in Kansas and poses a low risk to the general ...

PharmaJet ®, a company focused on improving the performance and outcomes of injectables through needle-free injection technology, announced that its partner, Brazilian Tuberculosis Research Network ...

The MarketWatch News Department was not involved in the creation of this content. -- PharmaJet's Needle-free intradermal (ID) injection device ("Tropis(R) ID") will be evaluated as delivery system for ...